<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01632553</url>
  </required_header>
  <id_info>
    <org_study_id>1678</org_study_id>
    <secondary_id>NF110946</secondary_id>
    <secondary_id>SOCSRG2594</secondary_id>
    <secondary_id>insurance/CT1349</secondary_id>
    <nct_id>NCT01632553</nct_id>
  </id_info>
  <brief_title>Cortisol Evaluation in Abuse Survivors</brief_title>
  <acronym>CEASE</acronym>
  <official_title>Longitudinal Measurement of Cortisol in Association With Mental Health and Experience of Domestic Violence and Abuse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bristol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals Bristol NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Survive South Gloucestershire and Bristol</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bristol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study looks at the biological effect of domestic violence and abuse (DVA) on women's
      mental health. The mechanisms through which DVA causes mental disorders are very poorly
      understood. Similar to other demands, DVA activates the biological stress system, of which
      the chief component is the hypothalamic-pituitary-adrenal (HPA) axis, which produces chemical
      cortisol. Cortisol levels increase in response to short-term demand and help organisms deal
      with it by changing the processes of getting energy from food and also mental function.
      However constant activation of the HPA axis can cause damage and accelerate disease.

      This study tests the hypothesis that compared to non-abused women all abuse victims have
      altered diurnal rhythm in cortisol secretion and that the pattern of this alteration is
      predicted by abuse characteristics, such as its type, severity, duration, and cessation. To
      examine the hypothesis the following research questions will be addressed: 1) whether
      cortisol levels are related to mental health state; 2) whether cortisol levels are related to
      type, severity, duration and cessation of DVA; 3) whether there is any difference in cortisol
      concentrations between those women exposed to both childhood abuse and DVA and those who have
      experienced only the latter; 4) whether cortisol levels vary between women, living in refuge
      and those not living in refuge?

      To answer these research questions 214 women will be recruited in a domestic violence agency.
      Baseline and 3-monthly follow-up measures will be taken over 6 months after recruitment.
      Women will be asked to fill in a questionnaire to evaluate their demographics, health,
      experience of childhood abuse and DVA. Women's weight and height will be taken. In addition
      participants will be asked to take three saliva samples: 1st in the evening in bed, 2nd -
      next morning immediately upon awakening, and the 3rd - in thirty minutes after awakening.
      Saliva will be collected by chewing (for 2 minutes) the cotton pledget provided with plastic
      tube and returned by post or via collection by the researcher. Then the saliva samples will
      be tested for cortisol and cortisone.

      Results of the study will increase our understanding of the biological mechanisms of DVA
      impact on a woman's health and tell researchers and practitioners about the possibility of
      using cortisol as an indicator to diagnose abuse-related health problems and assess
      effectiveness of medical care for abuse survivors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Domestic violence and abuse (DVA) is threatening behavior, violence or abuse (psychological,
      physical, sexual, financial or emotional) used by one person to control the other. Life time
      prevalence of DVA is 28% for women and 18% for men, although severity and consequences of
      abuse are less for men (1). Over and above damage to physical and reproductive health DVA has
      long-term detrimental effects on mental health for women consulting in primary care (2, 3). A
      meta-analysis of studies measuring the relationship between DVA and mental disorders reported
      increased risk for depression, anxiety, psychosomatic disorders, posttraumatic stress
      disorder (PTSD), alcohol abuse, and suicidal behavior (4). Kernic et al (5) have established
      that cessation of DVA among survivors is associated with decreased prevalence of depression;
      whereas Anderson and Sounders (6) have found that some women out of the abusive relationship
      may have greater psychological difficulties than those who are still in it. However the
      mechanisms through which DVA causes mental disease are very poorly understood. Similar to
      other stressors, DVA activates the biological stress system, of which the principal component
      is the hypothalamic-pituitary-adrenal (HPA) axis, which produces cortisol. Chronic activation
      of this system can result in dendritic retraction and hippocampal loss of function (7, 8).
      The results of existing cross-sectional studies testing the impact of DVA on women's HPA axis
      functioning are contradictory. Pico-Alfonso et al (9) have reported an increase in cortisol
      levels, whilst Seedat et al (10) have established reduction in cortisol levels in DVA
      subjects compared to controls. This disparity may relate to differential development of PTSD
      and/or depression within DVA-exposed samples (11). Currently, there is a hypothesis that DVA
      survivors may be characterized by alterations in the HPA axis (12) and that further
      longitudinal studies are needed to identify specific stress system disturbances in this group
      (1, 13). The aim of the study is to increase understanding of the role of
      hypothalamic-pituitary-adrenal (HPA) axis activity in DVA impact on women's mental health.

      Study objectives:

        -  To evaluate the profiles of the awakening response of cortisol, the diurnal variation
           and the mean salivary cortisol concentration in women with experience of DVA and in
           non-abused controls

        -  To estimate whether cortisol secretion is associated with type, severity, duration and
           cessation of DVA

        -  To investigate whether cortisol acts as mediator between DVA and mental health state

        -  To examine whether there is any distinction in cortisol levels between those women
           exposed to both childhood abuse and DVA and those experienced only the latter

        -  To explore whether cortisol secretion differs between women, living in a domestic
           violence refuge/safe house and those still living in the community (after adjustment for
           confounding effects of abuse severity and continuing contact with abuser).

      This 6-month study will consist of 3 measurements every 3 months. Each assessment will last
      approximately 30-45 minutes and will include:

        1. Numerous standardized self-administered psychological questionnaires

        2. Weight and height measurement

        3. Self-completion of 3 saliva samples using Salivette tubes:

             1. evening sample - at bedtime

             2. awakening sample - in the morning immediately upon wakening

             3. post-awakening sample - 30 mins after awakening sample

      Tubes with saliva will be returned by post or by researcher to an accredited laboratory for
      cortisol assay. The analysis also simultaneously measures cortisone a breakdown product of
      cortisol. This measurement is used to confirm the integrity of the sample.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diurnal cortisol variation</measure>
    <time_frame>Baseline, and at 3 and 6 months after baseline</time_frame>
    <description>Difference between awakening and bedtime cortisol concentrations. Assay: Ultra performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS). Unit of measure - nmol/l.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cortisol awakening response (CAR)</measure>
    <time_frame>Baseline, and at 3 and 6 months after baseline</time_frame>
    <description>Difference between awakening and post awakening cortisol concentrations. Assay: UPLC - MS/MS. Unit of measure - nmol/l.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean salivary cortisol concentration</measure>
    <time_frame>Baseline, and at 3 and 6 months after baseline</time_frame>
    <description>Sum of awakening, post awakening, and bedtime cortisol concentrations. Assay: UPLC - MS/MS. Unit of measure - nmol/l.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">214</enrollment>
  <condition>Domestic Violence</condition>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Panic Disorder</condition>
  <condition>Posttraumatic Stress Disorders</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>women who have experienced DVA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>women who have not experienced DVA</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women referred to two specialist domestic violence agencies for community outreach support
        or refuge accommodation by other agencies or self-referred. Non-abused friend and family
        controls will be recruited through index participants and in local communities through
        invitation letters displayed in public places in areas surrounding agencies sites.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age â‰¥ 18 y.o.

        Exclusion Criteria:

          -  unable to read English

          -  current use of steroid-based medications

          -  pregnancy

          -  presence of adrenal and/or pituitary gland disorder

          -  symptomatic psychotic illness.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gene Feder, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bristol, Centre for Academic Primary Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stafford Lightman, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bristol, School of Clinical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Natalia Lokhmatkina, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Bristol, School of Clinical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Survive South Gloucestershire and Bristol</name>
      <address>
        <city>Kingswood</city>
        <state>Bristol</state>
        <zip>BS15 8XJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Next Link</name>
      <address>
        <city>Bristol</city>
        <zip>BS1 4JQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.biomedcentral.com/1471-244X/13/188</url>
    <description>protocol paper in Open Access</description>
  </link>
  <reference>
    <citation>Feder G, Ramsay J, Dunne D, Rose M, Arsene C, Norman R, Kuntze S, Spencer A, Bacchus L, Hague G, Warburton A, Taket A. How far does screening women for domestic (partner) violence in different health-care settings meet criteria for a screening programme? Systematic reviews of nine UK National Screening Committee criteria. Health Technol Assess. 2009 Mar;13(16):iii-iv, xi-xiii, 1-113, 137-347. doi: 10.3310/hta13160. Review.</citation>
    <PMID>19272272</PMID>
  </reference>
  <reference>
    <citation>Campbell JC. Health consequences of intimate partner violence. Lancet. 2002 Apr 13;359(9314):1331-6. Review.</citation>
    <PMID>11965295</PMID>
  </reference>
  <reference>
    <citation>Coid J, Petruckevitch A, Chung WS, Richardson J, Moorey S, Feder G. Abusive experiences and psychiatric morbidity in women primary care attenders. Br J Psychiatry. 2003 Oct;183:332-9; discussion 340-1.</citation>
    <PMID>14519611</PMID>
  </reference>
  <reference>
    <citation>Golding JM. Intimate partner violence as a risk factor for mental disorders: A meta-analysis. Journal of Family Violence 14(2):99-132, 1999.</citation>
  </reference>
  <reference>
    <citation>Kernic MA, Holt VL, Stoner JA, Wolf ME, Rivara FP. Resolution of depression among victims of intimate partner violence: is cessation of violence enough? Violence Vict. 2003 Apr;18(2):115-29.</citation>
    <PMID>12816399</PMID>
  </reference>
  <reference>
    <citation>Anderson DK, Saunders DG. Leaving an abusive partner: an empirical review of predictors, the process of leaving, and psychological well-being. Trauma Violence Abuse. 2003 Apr;4(2):163-91. Review.</citation>
    <PMID>14697121</PMID>
  </reference>
  <reference>
    <citation>Lightman SL. The neuroendocrinology of stress: a never ending story. J Neuroendocrinol. 2008 Jun;20(6):880-4. doi: 10.1111/j.1365-2826.2008.01711.x. Review.</citation>
    <PMID>18601712</PMID>
  </reference>
  <reference>
    <citation>Mirescu C, Gould E. Stress and adult neurogenesis. Hippocampus. 2006;16(3):233-8. Review.</citation>
    <PMID>16411244</PMID>
  </reference>
  <reference>
    <citation>Pico-Alfonso MA, Garcia-Linares MI, Celda-Navarro N, Herbert J, Martinez M. Changes in cortisol and dehydroepiandrosterone in women victims of physical and psychological intimate partner violence. Biol Psychiatry. 2004 Aug 15;56(4):233-40.</citation>
    <PMID>15312810</PMID>
  </reference>
  <reference>
    <citation>Seedat S, Stein MB, Kennedy CM, Hauger RL. Plasma cortisol and neuropeptide Y in female victims of intimate partner violence. Psychoneuroendocrinology. 2003 Aug;28(6):796-808.</citation>
    <PMID>12812865</PMID>
  </reference>
  <reference>
    <citation>McFarlane AC, Barton CA, Yehuda R, Wittert G. Cortisol response to acute trauma and risk of posttraumatic stress disorder. Psychoneuroendocrinology. 2011 Jun;36(5):720-7. doi: 10.1016/j.psyneuen.2010.10.007. Epub 2010 Nov 19. Erratum in: Psychoneuroendocrinology. 2011 Nov;36(10):1587.</citation>
    <PMID>21093988</PMID>
  </reference>
  <reference>
    <citation>Heim C, Ehlert U, Hanker JP, Hellhammer DH. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med. 1998 May-Jun;60(3):309-18.</citation>
    <PMID>9625218</PMID>
  </reference>
  <reference>
    <citation>Dutton MA, Green BL, Kaltman SI, Roesch DM, Zeffiro TA, Krause ED. Intimate partner violence, PTSD, and adverse health outcomes. J Interpers Violence. 2006 Jul;21(7):955-68. Review.</citation>
    <PMID>16731994</PMID>
  </reference>
  <reference>
    <citation>Lokhmatkina NV, Feder G, Blake S, Morris R, Powers V, Lightman S. Longitudinal measurement of cortisol in association with mental health and experience of domestic violence and abuse: study protocol. BMC Psychiatry. 2013 Jul 13;13:188. doi: 10.1186/1471-244X-13-188.</citation>
    <PMID>23849084</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2012</study_first_submitted>
  <study_first_submitted_qc>June 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2012</study_first_posted>
  <last_update_submitted>December 4, 2015</last_update_submitted>
  <last_update_submitted_qc>December 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bristol</investigator_affiliation>
    <investigator_full_name>Gene Feder</investigator_full_name>
    <investigator_title>Professor of Primary Health Care, Centre for Academic Primary Care</investigator_title>
  </responsible_party>
  <keyword>Observation</keyword>
  <keyword>Domestic Violence</keyword>
  <keyword>Partner Abuse</keyword>
  <keyword>Spousal Abuse</keyword>
  <keyword>Battered Women</keyword>
  <keyword>Abused Women</keyword>
  <keyword>Cortisol</keyword>
  <keyword>Mental Health</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Posttraumatic Stress Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

